Skip to main content
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. — Investor Relations & Filings

Ticker · BNGO ISIN · US09075F1075 LEI · 54930086AP7ROH0VJ631 US Manufacturing
Filings indexed 481 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country US United States of America
Listing US BNGO

About Bionano Genomics, Inc.

https://bionano.com/

Bionano Genomics is a life sciences company specializing in genome analysis. Its core technology, Optical Genome Mapping (OGM), provides high-resolution, genome-wide detection of all classes of structural variants (SVs), which are often missed by traditional sequencing and cytogenetic methods. The company offers an integrated workflow that includes the Ionic® system for DNA isolation, the Saphyr® and Stratys™ systems for OGM data generation, and the VIA™ software platform. The VIA software uniquely integrates and visualizes data from OGM, next-generation sequencing (NGS), and microarrays for comprehensive genomic interpretation. Bionano's solutions are used by researchers and clinicians in applications including oncology, genetic diseases, cell bioprocessing quality control, and cytogenomics.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2026-05-14 English
8-K - Bionano Genomics, Inc. (0001411690) (Filer)
Regulatory Filings
2026-05-13 English
S-3 - Bionano Genomics, Inc. (0001411690) (Filer)
Registration Form
2026-05-08 English
DEF 14A - Bionano Genomics, Inc. (0001411690) (Filer)
Proxy Solicitation & Information Statement
2026-04-02 English
S-8 - Bionano Genomics, Inc. (0001411690) (Filer)
Registration Form
2026-03-25 English
4 - BIONANO GENOMICS, INC. (0001411690) (Filer)
Director's Dealing
2026-02-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.